Ophthalmology

The AJMC® Ophthalmology compendium is a comprehensive resource for clinical news and expert insights for treatment of disorders of the eye.

Latest News

Close up of a woman's eye | Image credit: Artem Markin - stock.adobe.com
5 Things About Diabetic Eye Disease

November 29th 2024

November is Diabetic Eye Disease Awareness Month. Diabetes is the leading cause of preventable blindness in the US. Here is a look at recent research related to diabetic eye diseases.

Amblyopia | Image credit: sasha1806 - stock.adobe.com
Visual Acuity Improvements Found After Rehabilitation With Digital Video Games

November 27th 2024

Glaucoma | Image credit: Alessandro Grandini - stock.adobe.com
Polygenic Risk Scores Can Identify Patients Who Should Receive IOP-Lowering Treatment

November 21st 2024

Eye | Image credit: Liudmila Dutko - stock.adobe.com
Atsena Therapeutics and Nippon Shinyaku Enter Exclusive License Agreement for ATSN-101

November 13th 2024

Glaucoma | Image credit: Yakobchuk Olena - stock.adobe.com
Polygenic Risk Score Important to Track POAG Onset

November 12th 2024

Continuing Medical Education
View All
December 3rd 2024

Navigating the Advances in the Treatment of Geographic Atrophy: Updates and Strategies for Managed Care

2.0 Credits / Ophthalmology/Optometry
December 3rd 2024

Application of Recent Data in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Managed Care Insights and Strategies

1.5 Credits / Ophthalmology, Optometry
December 3rd 2024

Patient-Centered Treatment Plans for Management of Neovascular (Wet) AMD and Diabetic Macular Edema: Insights on Recent Efficacy, Safety, and Real-World Data to Improve Adherence and Outcomes

1.5 Credits / Ophthalmology/Optometry
December 3rd 2024

Integrating Multi-Cancer Early Detection Tests Into Clinical Practice: The Health Economics Perspective for Managed Care Professionals

1.5 Credits / Oncology
December 3rd 2024

The Evolving Strategies for Managing nAMD and DME: Empowering Managed Care Decisions for Improved Patient Outcomes

1.5 Credits / Endocrinology, Diabetes & Metabolism, Ophthalmology/Optometry

More News

Erasing eye vision.
September 15th 2021

Comorbid Ophthalmic, Systemic Conditions Linked With Higher Risk of Dementia

Matthew Gavidia
People with both ophthalmic and systemic conditions were found to be at higher risk of dementia compared with those with only 1 such condition. Some ophthalmic conditions—age-related macular degeneration, cataract, and diabetes-related eye disease—also increased risk on their own.
Rajesh Rajpal, MD.
September 11th 2021

Dr Rajesh Rajpal Reviews Latest Innovations in Cataract Surgery

Rajesh Rajpal, MD, chief medical officer, global head of clinical medical affairs, Johnson & Johnson Vision, discusses the surgical options available to patients undergoing cataract surgery.
Children.
September 10th 2021

School-Based Vision Program Shown to Improve Short-term Academic Performance in Adolescents

Matthew Gavidia
Students in grades 3 to 7 who were given eyeglasses as part of a school-based vision program were found to achieve better reading scores and exhibit improved academic achievement over 1 year.
Human eye.
September 2nd 2021

Ophthalmology Overview: Managing a Practice, Weight Loss Lessens Risk of Cataract, and More

Matthew Gavidia
Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.
Eye of an elderly woman.
August 31st 2021

Study Finds Increased Dosage of Timolol-Dorzolamide Fixed Combination Safe, Effective in Open-Angle Glaucoma

Matthew Gavidia
Increasing the dosage of timolol-dorzolamide fixed combination from twice a day to 3 times a day was found to be safe and significantly more effective in reducing intraocular pressure in patients with open-angle glaucoma, although further research on safety may be warranted.
Rajesh Rajpal, Johnson & Johnson Vision.
August 27th 2021

Dr Rajesh Rajpal on Eye Health Implications of Visual Needs in Younger Populations

Rajesh Rajpal, MD, chief medical officer, global head of clinical medical affairs, Johnson & Johnson Vision, discusses how greater visual needs are contributing to adverse eye health in younger populations.
Patient with physician.
August 25th 2021

Study Finds Significant Glaucoma Surgery, Mortality Risk Link in Elderly Patients

Matthew Gavidia
Elderly patients who underwent surgery for glaucoma had a greater risk of all-cause and cause-specific mortality than those who did not have surgery, including greater risk of cancer and neurologic cause–related mortality.
Eye health graphic
August 24th 2021

Presurgery Corticosteroids May Worsen Conjunctival Hyperemia Post Trabeculectomy

Jared Kaltwasser
A new report suggests corticosteroids likely are not a panacea for ocular surface disease, a potential adverse effect of trabeculectomy.
Eye in sunglight.
August 21st 2021

Aflibercept Likely to Improve Severity, Complications of Nonproliferative Diabetic Retinopathy

Matthew Gavidia
Findings of the PANORAMA randomized clinical trial show that when patients with severe nonproliferative diabetic retinopathy were treated with intravitreal aflibercept, severity improved over 100 weeks and the likelihood of vision-threatening complications significantly reduced.
Health care worker with patient.
August 19th 2021

Low Safety Risk Observed in Office-Based, Operating Room Anti-VEGF Intravitreal Injections

Matthew Gavidia
A low risk of adverse safety outcomes was observed in anti–vascular endothelial growth factor (VEGF) intravitreal injections performed in office-based and operating room settings, with a higher rate of culture-positive endophthalmitis found in the office setting.
Rajesh Rajpal, MD, Johnson & Johnson Vision.
August 13th 2021

Dr Rajesh Rajpal Discusses Screen Usage, Eye Issues Amid the Pandemic

Rajesh Rajpal, MD, chief medical officer, global head of clinical medical affairs, Johnson & Johnson Vision, speaks on the impact of screen usage for eyes and trends in eye symptom burden reported amid the pandemic.
Human eye.
August 11th 2021

Ophthalmology Overview: Surge in Laser Vision Correction Procedures, Glaucoma Prevalence in West Africa, and More

Matthew Gavidia
Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.
Human eye.
August 7th 2021

Ophthalmology Overview: Bevacizumab BLA in Wet AMD, Long COVID-19 and Corneal Nerve Damage, and More

Matthew Gavidia
Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.
Approved stamp
August 5th 2021

Aetna Requires Precertification for All Cataract Surgeries, Angering Ophthalmologists

Lauren Massaro
The health insurance provider said it believes up to 20% of all cataract surgeries may be unnecessary, but ophthalmology groups disagree.
Rajesh Rajpal, MD, chief medical officer, global head of clinical medical affairs, Johnson & Johnson Vision.
July 31st 2021

Dr Rajesh Rajpal on US Prevalence of Cataracts, Risk Factors for Younger Populations

Rajesh Rajpal, MD, chief medical officer, global head of clinical medical affairs, Johnson & Johnson Vision, discusses the process of cataract development and its prevalence in both older and younger populations.
Human eye.
July 29th 2021

Ophthalmology Overview: 2022 Physician Fee Schedule Implications, Personalizing Glaucoma Surgery, and More

Matthew Gavidia
Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.
Gene therapy
July 22nd 2021

Gene Therapy Associated With Vision Preservation in Retinal Disease

Lauren Massaro
The manipulation of key enzymes through methods of gene therapy was shown to provide protection against vision loss from multiple retinal conditions.
Bobeck Modjtahedi, MD
July 19th 2021

Dr Bobeck Modjtahedi Outlines Limitations of Telehealth Use for Diabetic Retinopathy

Gianna Melillo
Bobeck Modjtahedi, MD, highlights some of the challenges of using telehealth to treat individuals with diabetic retinopathy.
Human eye.
July 15th 2021

Ophthalmology Overview: Pediatric Eye Examinations, How Diet Affects Glaucoma, and More

Matthew Gavidia
Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.
Team Creates Algorithm to Allocate Gene Therapy for Patients With Inherited Vision Loss
July 11th 2021

Team Creates Algorithm to Allocate Gene Therapy for Patients With Inherited Vision Loss

Jared Kaltwasser
The development of a successful gene therapy for RPE65-associated inherited retinal disease is a major breakthrough, but it also prompts difficult questions about which patients are good candidates for the therapy.
Female patient with a physician.
July 10th 2021

Hormonal Contraceptive Use Associated With Increased Risk of Glaucoma in Women

Matthew Gavidia
Hormonal contraceptive use among women of childbearing age was associated with a more than 2-fold higher risk of developing glaucoma, although risk was still relatively low.
Human eye.
July 9th 2021

Ophthalmology Overview: Racial Inequities in Ocular Health Care, Eye Implications of Alzheimer Disease, and More

Matthew Gavidia
Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.
Eye exam
June 30th 2021

Preservative-Free Beta-blockers Appear to Hold Up Well Against Preserved Formulations in Treating Glaucoma

Jared Kaltwasser
A new meta-analysis finds rigorous evidence lacking; however, existing data suggest preservative-free formulations of beta-blockers may work just as well as preserved beta-blockers in reducing intraocular pressure.
Human eye.
June 24th 2021

Ophthalmology Overview: Early Diagnosis of Blinding Diseases, Increasing Access to Eye Care, and More

AJMC Staff
Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.
Human eye.
June 18th 2021

Ophthalmology Overview: Unraveling Biological Pathways of Glaucoma, Classification for Uveitis Subtypes, and More

AJMC Staff
Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.
Magnified eye image
June 16th 2021

New Study Data May Help Shape Treatments for Ocular Hypertension

Larry Hanover
Over 20 years, 1 in 4 patients with ocular hypertension suffered visual field loss from primary open-angle glaucoma, according to a new study.
Human eye.
June 10th 2021

Ophthalmology Overview: Addressing Dry Eye in Sjogren Syndrome, Chronic Uveitis Treatment, and More

AJMC Staff
Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.
graphical image of brain as circuit
June 10th 2021

Experts Develop Classification Criteria to Distinguish 25 Most Common Uveitides

Lauren Massaro
Classification criteria developed using machine learning will allow doctors to conduct disease-specific research about this collection of inflammatory eye diseases.
Human eye.
June 5th 2021

Ophthalmology Overview: Bevacizumab for Wet AMD, AI in Retinal Disease Management, and More

AJMC Staff
Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.
green color
June 4th 2021

Lighting System Quality May Impact Color Discrimination in Patients With Glaucoma

Jaime Rosenberg
Patients with glaucoma who were tested under a quantum dot LED were able to better distinguish differences in color, indicating that the quality of light systems may have an impact on color discrimination.
<1
...
67891011121314
...
17>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo